Press "Enter" to skip to content

Nanostics Launches Pivotal Study to Validate ClarityDX Prostate Diagnostic Test – Prostate Cancer News Today

admin 0

Nanostics Launches Pivotal Study to Validate ClarityDX Prostate Diagnostic Test  Prostate Cancer News Today

Nanostics has started a pivotal clinical study in Canada to validate ClarityDX Prostate, a novel blood test for the early diagnosis of prostate cancer.

“prostate cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *